X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 45 filers reported holding X4 PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,737 | -43.8% | 61,227 | 0.0% | 0.00% | – |
| Q2 2023 | $118,780 | +32.0% | 61,227 | +486.5% | 0.00% | – |
| Q1 2021 | $90,000 | +23.3% | 10,439 | -8.5% | 0.00% | – |
| Q4 2020 | $73,000 | +32.7% | 11,411 | +39.6% | 0.00% | – |
| Q3 2020 | $55,000 | -22.5% | 8,172 | +7.5% | 0.00% | – |
| Q2 2020 | $71,000 | +26.8% | 7,600 | +36.3% | 0.00% | – |
| Q1 2020 | $56,000 | -28.2% | 5,577 | -24.9% | 0.00% | – |
| Q4 2019 | $78,000 | +66.0% | 7,426 | +94.0% | 0.00% | – |
| Q3 2019 | $47,000 | -39.7% | 3,827 | -27.4% | 0.00% | – |
| Q2 2019 | $78,000 | +13.0% | 5,272 | +30.1% | 0.00% | – |
| Q1 2019 | $69,000 | – | 4,053 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 311,492 | $2,025,000 | 3.24% |
| AIGH Capital Management LLC | 1,438,899 | $9,353,000 | 1.68% |
| Ikarian Capital, LLC | 2,719,290 | $17,676,000 | 1.43% |
| Sio Capital Management, LLC | 804,597 | $5,230,000 | 1.30% |
| Bain Capital Life Sciences Investors, LLC | 2,119,540 | $13,777,000 | 0.90% |
| SV Health Investors, LLC | 311,490 | $2,025,000 | 0.88% |
| Worth Venture Partners, LLC | 334,684 | $2,175,000 | 0.81% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $2,178,000 | 0.56% |
| Abingworth LLP | 229,885 | $1,494,000 | 0.46% |
| Monashee Investment Management LLC | 574,712 | $3,736,000 | 0.45% |